| Title | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I |
| ToC Doc | Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I |
| Docket Number | 2022-14372 |
| Type | Proposed Rule |
| Subject | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I |
| Publication Date | 2022-07-06 |
| Last Updated Date | 2022-07-05 08:15:10 -0400 |
| Last Public Inspection | 2022-07-05 |
| Filed At | 2022-07-05T08:45:00.000-04:00 |
| 2022-14372_PI.pdf (106394 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 4 |
| Filing Type | regular |
| Agencies | Drug Enforcement Administration |
You can find the raw source document below...